Albany, NY — 12/15/2017 — According to the latest report compiled by Transparency Market Research (TMR), the global single-use bioreactors market is expected to witness robust growth. It is also estimated to increase to 13.5% CAGR throughout the forecast period 2017-2026. The market is also projected to reach US$ 1,547.3 million revenue by 2026 end.
The Global Single-Use Bioreactors Market is segmented on the basis of product type, End User, Cells Type, and Molecule Type.
The global single-use bioreactors market is segmented on the basis of product type, cells type, end user and molecule type. Based on the product type, the segmentation consists of media bags, single use bioreactor systems and filtration assemblies. Among these, single use bioreactor systems are anticipated to witness significant growth throughout the forecast period. Based on the cells type, the market is categorized into bacterial cells, mammalian cells, yeast cells, and others. Between 2017 and 2026, mammalian cells are expected to witness the highest growth.
Read Report Overview @ https://www.transparencymarketresearch.com/single-use-bioreactors-market.html
By end user, biopharmaceutical companies are anticipated to emerge as the largest users of the single-use bioreactors during 2017-2026. In the terms of molecule type, the segment includes gene-modified cells, stem cells, vaccines, monoclonal antibodies (MABS) and others. Among aforementioned molecule types, monoclonal antibodies (MABS) is likely to witness strong growth in the global single-use bioreactors market between 2017 and 2026.
Europe is anticipated to be the most dominating region in the global single-use bioreactors market during 2017-2026. Owing to the presence of some of the world's leading pharmaceutical companies in Europe, the region is likely to witness growth. The region is expected to account for the largest share, due to the patient cliff of many biologics drugs in the region and the strong support by the government to the biopharmaceutical companies in order to establish new therapies in biologics. Also, the increasing use of single-use bioreactors in cell culture-based manufacturing is driving the demand in the region. Single-use bioreactors are also becoming technologically advanced and are also being provided at competitive cost.
Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2108
Meanwhile, North America and APEJ are also likely to witness growth in the single-use bioreactors market. Increasing investment by biopharmaceutical companies to establish their manufacturing facilities is driving the growth in APEJ. Increasing focus on research activities and well-established healthcare industry is resulting in the growth of the market in North America.
Summary of Table of Content
1 Global Economic Outlook
2 Global Single-Use Bioreactors Market – Executive Summary
3 Global Single-Use Bioreactors Market Overview
4 Global Single-Use Bioreactors Market Analysis and Forecast 2012-2026
5 North America Single-Use Bioreactors Market Size and Forecast, 2012-2026
6 Latin America Single-Use Bioreactors Market Size and Forecast, 2012-2026
7 Europe Single-Use Bioreactors Market Size and Forecast, 2012-2026
8 Japan Single-Use Bioreactors Market Size and Forecast, 2012-2026
9 APEJ Single-Use Bioreactors Market Size and Forecast, 2012-2026
10 MEA Single-Use Bioreactors Market Size and Forecast, 2012-2026
11 Global Single-Use Bioreactors Market – Competitive Landscape and Company Profiles
12 TMR Research Methodology
13 Disclaimer and Contact information
Request to Browse Full Table of Content, figure and Tables @ https://www.transparencymarketresearch.com/report-toc/2108
Latest posts by Sarah Thompson (see all)
- Houston, We Have Authentic Flavor: Coast Packingâ€™s â€˜Taste the Differenceâ€™ Online Guide Showcases Lard and Beef Tallow on the Menu - February 22, 2018
- Tinyclues Closes $18 Million Investment Round for International Growth - February 22, 2018
- Protein Ingredients Market Worth $48.77 Billion by 2025 | CAGR: 7.4%: Grand View Research, Inc. - February 22, 2018